Search Results 771-780 of 16877 for Antagonist
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
A study of tolododekin alfa (also known as ANK-101) administered in combination with an anti-programmed cell death protein 1 (PD-1)/programmed cell death ligand ...
The purpose of this study is to determine the response rate to PLX-038 in patients with metastatic ovarian, primary peritoneal, and fallopian tube cancers that ...
The purpose of this study is to analyze how the immune cell repertoire changes during early and late metastasis which could shed light into how the tumor ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.